Cognios Beta Neutral Large Cap Fund’s Biogen BIIB Stock Holding History

Cognios Beta Neutral Large Cap Fund’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$442K	Buy	+2,052	New	+$481K	0.58%	73
2023 Q4	–	Sell	-1,080	Closed	-$278K	–	98
2023 Q3	$278K	Sell	1,080 -1,569	-59%	-$420K	0.36%	96
2023 Q2	$755K	Sell	2,649 -1,159	-30%	-$345K	0.88%	39
2023 Q1	$1.05M	Buy	3,808 +22	+0.6%	+$6.09K	1%	28
2022 Q4	$1.05M	Buy	+3,786	New	+$1.07M	1.01%	27

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cognios Beta Neutral Large Cap Fund's BIIB Position: Q1 2024 in Review

Cognios Beta Neutral Large Cap Fund opened a new position in Biogen (BIIB) in Q1 2024: 2,052 shares worth $442K. The stake represents 0.58% of the portfolio and ranks #73 among its holdings. This is a return to the name: Cognios Beta Neutral Large Cap Fund previously reported a position in BIIB as recently as Q3 2023.

Cognios Beta Neutral Large Cap Fund first reported a position in BIIB in Q4 2022 and has held it in 5 quarters since. The position peaked at $1.05M in Q1 2023. 955 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

Cognios Beta Neutral Large Cap Fund held 2,052 shares of Biogen worth $442K as of Q1 2024.
Biogen was a new Cognios Beta Neutral Large Cap Fund position in Q1 2024.
Biogen made up 0.58% of Cognios Beta Neutral Large Cap Fund's portfolio in Q1 2024, its #73 holding.
Cognios Beta Neutral Large Cap Fund first reported a position in Biogen in Q4 2022 and has held it in 5 quarters since.
Cognios Beta Neutral Large Cap Fund's Biogen position peaked at $1.05M in Q1 2023.
955 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on Cognios Beta Neutral Large Cap Fund's 13F filing for Q1 2024, filed 8 May 2024.